TPST
Tempest Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Tempest Therapeutics (TPST) Stock: Buy, Sell, or Hold?
$0.38
0.00 (-0.29%)
▼
5d:
+0.34%
30d:
-39.86%
90d:
-66.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$0.43 – $0.70
Position: OVERSOLD
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$7.00
+1732.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.34 / $0.51
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TPST shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When TPST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TPST is currently trading at $0.38, which is considered oversold relative to its 30-day fair value range of $0.43 to $0.70.
Technical Outlook: Technically, TPST is in a strong downtrend. Immediate support is located at $0.34, while resistance sits at $0.51.
Market Sentiment: TPST scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+1732.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TPST is in a strong downtrend. Immediate support is located at $0.34, while resistance sits at $0.51.
Market Sentiment: TPST scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+1732.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.43 -
$0.70
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.43 -
$0.70
Current vs Trading Range
OVERSOLD
Support Level
$0.34
Resistance Level
$0.51
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1732.9% below Wall St target ($7.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.42
Wall Street Target
$7.00
(+1732.9%)
Share TPST Analysis
Share this live TPST analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TPST)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Tempest Therapeutics exercises option to license Senlang's CD7-targeted lentiviral platform and BCMA/GPRC5D dual-targeting CAR-T candidate TPST-4903, with encouraging initial Phase 1 results.
Key Retail Themes:
Company's licensing deal with Senlang
Encouraging initial Phase 1 results for TPST-4903
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 11:57 AM ET
Data refreshes hourly during market hours. Next update: 12:57 PM
Data refreshes hourly during market hours. Next update: 12:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TPST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 45 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TPST Research Pages
